References
- Dilsizian V, Bonow RO. Current diagnostic techniques
of assessing myo-cardial viability in patients with hibernating and
stunned myocardium. Circulation. 1993;87:2-20.
- Holman BL. Nuclear cardiology. In: Braunwald E, ed.
Heart Disease. A Textbook of Cardiovascular Medicine. 3rd ed. Philadelphia,
Pa: WB Saunder Co; 1988:311-355.
- Bonow RO, Dilsizian V. Thallium-201 and technetium-99m-sestamibi
for assessing viable myocardium. J Nucl Med. 1992; 33:815-818.
- Higley B, Smith FW, Smith T, et. al. Technetium-99m-l,2-bis[bis(2-
ethoxyethyl)phosphino]ethane: human biodistribution, dosimetry and
safety of a new myocardial perfusion imaging agent. J Nucl Med. 1993;34:30-38.
- Sridhara BS, Braat S, Rigo P, et al. Comparison of
myocardial perfusion imaging with technetium-99m tetrofosmin versus
thallium-201 in coronary artery disease. Am J Cardiol. 1993;72:1015-1019.
- Jones S, Hendel RC. Technetium-99m tetrofosmin: a new
myocardial perfusion agent. Journal of Nuclear Medicine Technology.
1993;21:191-195.
- Data on file, Amersham International pIc, Amersham,
England.
- Garcia EV, Cooke CD, Van Train KF, et. al. Technical
aspects of myocardial SPECT imaging with technetium-99m sestamibi.
Am J Cardiol. 1990; 66:23E-31E.
- Leppo JA, DePuey EG, Johnson LL. A review of cardiac
imaging with sestamibi and teboroxime. J Nucl Med. 1991;32:2012-2022.
- Sinusas AJ, Wacker FJTh. Assessing myocardial reperfusion
with technetium-99m-labeled myocardial perfusion agents: basic concepts
and clinical applications. American Journal of Cardiac Imaging. 1993;7(1):24-38.
- MYOVIEWTM prescribing information.
- Dahlberg ST, Gilmore MP, Leppo JA. Effect of coronary
blood flow on the "uptake" of tetrofosmin in the isolated rabbit heart. J Nucl Med 1992;33(5,suppl):846.
Abstract.
- Riemersma RA, Shyam-Sundar A, Millar A, Higley B. A
new flow marker Tc99m-tetrofosmin: relationship to myocardial blood
flow during ischaemia. Presented at British Cardiac Society; May 18-21,
1993; Wembley, England.
- Jain D, Wackers FJT, Mattera J, McMahon M, Sinusas
AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin; myocardial
perfusion imaging agent: implications for a one-day imaging protocol.
J Nucl Med. 1993;34:1254-1259.
- Zaret BL, Rigo P, Wackers FJTh, et. al. Myocardial
perfusion imaging with technetium-99m-tetrofosmin: comparison to thallium-201
imaging and coronary angiography in a phase III multicenter trial.
Circulation. 1995; 91(2): 313-319.
- Susaki Y, Nishimura T, Kubo A, et al. Evaluation of
the safety and clinical usefulness of a new myocardial imaging agent
Technetium-99m PPNI011 multicenter phase II clinical trial report.
Japanese Journal of Nuclear Medicine. 1993;30(1):25-40.
<< Previous | Table
of content | Next >> |
